Clinical validity of autosomal dominant ALPK3 loss-of-function variants as a cause of hypertrophic cardiomyopathy
Authors: Sophie Hespe; Emma S Singer; Chloe Reuter; Brittney Murray; Elizabeth Jordan; Jessica Chowns; Stacey Peters; Megan Mayers; Belinda Gray; Ray E Hershberger; Anjali T Owens; Christopher Semsarian; Amber Waddell; Babken Asatryan; Emma Owens; Courtney Thaxton; Mhy-Lanie Adduru; Kailyn Anderson; Emily E Brown; Lily Hoffman-Andrews; Fergus Stafford; Richard D Bagnall; Lucas Bronicki; Bert Callewaert; C Anwar A Chahal; Cynthia A James; Olga Jarinova; Andrew P Landstrom; Elizabeth M McNally; Laura Muiño-Mosquera; Victoria Parikh; Roddy Walsh; Bess Wayburn; James S Ware; Benjamin L Parker; Enzo R Porrello; David A Elliott; James W McNamara; Jodie Ingles
Collaborators: Amsterdam University Medical Center; Children's Hospital of Eastern Ontario Research Institute; Duke University School of Medicine; Garvan Institute of Medical Research; Ghent University; Ghent University Hospital; Imperial College London; Johns Hopkins University School of Medicine; Mayo Clinic; Northwestern University Feinberg School of Medicine; Ohio State University (OSU); Perelman School of Medicine at the University of Pennsylvania; Queen Mary University of London; Royal Brompton & Harefield Hospitals NHS Trust; Royal Melbourne Hospital; Stanford; The Royal Children's Hospital; University of Melbourne; University of New South Wales; University of North Carolina at Chapel Hill; University of Ottawa; University of Sydney; University of Washington
Journal: Circulation: Genomic and Precision Medicine